Skip to main content
$116.54 -$9.50 (-7.5%)

04:00 PM EST on 02/25/21

ShockWave Medical (NASDAQ:SWAV)

CAPS Rating: 5 out of 5

Current Price $116.54 Mkt Cap $4.3B
Open $123.55 P/E Ratio 0.00
Prev. Close $116.54 Div. (Yield) $0.00 (0.0%)
Daily Range $115.10 - $126.93 Volume 362,583
52-Wk Range $22.01 - $143.79 Avg. Daily Vol. 423,776

Caps

How do you think NASDAQ:SWAV will perform against the market?

Add Stock to CAPS Watchlist

All Players

189 Outperform
1 Underperform
 

All-Star Players

125 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SWAV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ard699 (< 20)
Submitted December 29, 2020

Extremely easy for interventional cardiologists to learn to use. Very safe with negligible risks or complications. Improves PCI outcomes. About to be FDA approved ( probably in March) for Treatment of CAD. Once Covid ends and cardiac devices are… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:SWAV VS S&P 500 (SPY)

NASDAQ:SWAV Summary

Fools bullish on NASDAQ:SWAV are also bullish on:

Fools bearish on NASDAQ:SWAV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SWAV.

Recs

0
Member Avatar italianbarber (94.01) Submitted: 2/16/2021 10:58:11 PM : Outperform Start Price: $135.82 NASDAQ:SWAV Score: -12.12

Shockwave $SWAV Intravascular Lithotripsy approved for use by the FDA on route to become new standard of care in cardiac indications

Recs

0
Member Avatar Oranicus (95.81) Submitted: 2/8/2021 2:47:53 PM : Outperform Start Price: $115.75 NASDAQ:SWAV Score: -0.50

Innovative and unique process for cleaning calcifications in blood vessels. 100 bagger?

Recs

2
Member Avatar ard699 (< 20) Submitted: 12/29/2020 4:52:11 PM : Outperform Start Price: $100.52 NASDAQ:SWAV Score: +13.23

Extremely easy for interventional cardiologists to learn to use. Very safe with negligible risks or complications. Improves PCI outcomes. About to be FDA approved ( probably in March) for Treatment of CAD. Once Covid ends and cardiac devices are approved this stock will soar . I don’t think Wall Street gets how big a leap that IVL is. Other uses also will be forthcoming such as treatment of calcific aortic stenosis and treatment of access sights for TAVR

Leaderboard

Find the members with the highest scoring picks in SWAV.

Score Leader

SuperKid7

SuperKid7 (< 20) Score: +325.50

The Score Leader is the player with the highest score across all their picks in SWAV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SuperKid7 < 20 3/23/2020 Outperform 5Y $23.58 +394.23% +68.73% +325.50 0 Comment
Toprope101 99.48 3/16/2020 Outperform 5Y $25.66 +354.17% +54.00% +300.17 0 Comment
LifeDaddy < 20 3/24/2020 Outperform 5Y $26.20 +344.81% +59.08% +285.73 0 Comment
lancealot 98.77 4/1/2020 Outperform 5Y $27.02 +331.31% +55.07% +276.24 0 Comment
psylvester 97.84 9/30/2019 Outperform 5Y $29.78 +291.34% +29.18% +262.16 0 Comment
TMFFishBiz 70.08 9/30/2019 Outperform 5Y $30.01 +288.34% +28.67% +259.67 0 Comment
MelonsMangos 99.11 10/3/2019 Outperform 5Y $29.86 +290.29% +32.10% +258.19 0 Comment
TheCabbageMan 98.06 10/2/2019 Outperform 5Y $30.15 +286.53% +31.16% +255.37 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jasonuwbadger < 20 10/15/2019 Outperform 5Y $30.60 +280.85% +28.63% +252.22 0 Comment
Vavoom11 99.96 3/13/2020 Outperform 5Y $29.07 +300.89% +49.37% +251.53 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SWAV.